A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 24, 2021

Primary Completion Date

July 15, 2022

Study Completion Date

August 2, 2022

Conditions
Major Depressive Disorder
Interventions
DRUG

10 mg PRAX-114

Once daily oral treatment

DRUG

20 mg PRAX-114

Once daily oral treatment

DRUG

40 mg PRAX-114

Once daily oral treatment

DRUG

60 mg PRAX-114

Once daily oral treatment

DRUG

Placebo

Once daily oral treatment

Trial Locations (24)

3174

Praxis Research Site, Noble Park

11516

Praxis Research Site, Cedarhurst

14618

Praxis Research Site, Rochester

18104

Praxis Research Site, Allentown

19063

Praxis Research Site, Media

20877

Praxis Research Site, Gaithersburg

22903

Praxis Research Site, Charlottesville

30030

Praxis Research Site, Decatur

30331

Praxis Research Site, Atlanta

32256

Praxis Research Site, Jacksonville

32763

Praxis Research Site, Orange City

32801

Praxis Research Site, Orlando

38119

Praxis Research Site, Memphis

45417

Praxis Research Site, Dayton

63368

Praxis Research Site, O'Fallon

78737

Praxis Research Site, Austin

89102

Praxis Research Site, Las Vegas

91945

Praxis Research Site, Lemon Grove

92056

Praxis Research Site, Oceanside

92374

Praxis Research Site, Redlands

94549

Praxis Research Site, Lafayette

98201

Praxis Research Site, Everett

02131

Praxis Research Site, Boston

01655

Praxis Research Site, Worcester

Sponsors
All Listed Sponsors
lead

Praxis Precision Medicines

INDUSTRY